78 related articles for article (PubMed ID: 18418864)
1. Human germline and somatic cells have similar TP53 and Kirsten-RAS gene single base mutation frequencies.
Cole DN; Carlson JA; Wilson VL
Environ Mol Mutagen; 2008 Jul; 49(6):417-25. PubMed ID: 18418864
[TBL] [Abstract][Full Text] [Related]
2. Single base instability is promoted in vulvar lichen sclerosus.
Tapp RA; Feng J; Jones JW; Carlson JA; Wilson VL
J Invest Dermatol; 2007 Nov; 127(11):2563-76. PubMed ID: 17554370
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.
Palacio-Rúa KA; Isaza-Jiménez LF; Ahumada-Rodríguez E; Muñetón-Peña CM
Rev Gastroenterol Mex; 2014; 79(2):79-89. PubMed ID: 24861525
[TBL] [Abstract][Full Text] [Related]
4. The impact of TP53 and RAS mutations on cerebellar glioblastomas.
Milinkovic VP; Skender Gazibara MK; Manojlovic Gacic EM; Gazibara TM; Tanic NT
Exp Mol Pathol; 2014 Oct; 97(2):202-7. PubMed ID: 25036404
[TBL] [Abstract][Full Text] [Related]
5. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
[TBL] [Abstract][Full Text] [Related]
6. Detection of point mutations of K-ras oncogene and p53 tumor-suppressor gene in sputum samples.
Gao W; Keohavong P
Methods Mol Biol; 2014; 1105():325-44. PubMed ID: 24623240
[TBL] [Abstract][Full Text] [Related]
7. Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.
Sasaki H; Okuda K; Kawano O; Endo K; Yukiue H; Yokoyama T; Yano M; Fujii Y
Oncol Rep; 2007 Sep; 18(3):623-8. PubMed ID: 17671710
[TBL] [Abstract][Full Text] [Related]
8. Rapid screening assay for KRAS mutations by the modified smart amplification process.
Tatsumi K; Mitani Y; Watanabe J; Takakura H; Hoshi K; Kawai Y; Kikuchi T; Kogo Y; Oguchi-Katayama A; Tomaru Y; Kanamori H; Baba M; Ishidao T; Usui K; Itoh M; Cizdziel PE; Lezhava A; Ueda M; Ichikawa Y; Endo I; Togo S; Shimada H; Hayashizaki Y
J Mol Diagn; 2008 Nov; 10(6):520-6. PubMed ID: 18832461
[TBL] [Abstract][Full Text] [Related]
9. Needle-in-a-haystack detection and identification of base substitution mutations in human tissues.
Wilson VL; Wei Q; Wade KR; Chisa M; Bailey D; Kanstrup CM; Yin X; Jackson CM; Thompson B; Lee WR
Mutat Res; 1999 Aug; 406(2-4):79-100. PubMed ID: 10479725
[TBL] [Abstract][Full Text] [Related]
10. ACB-PCR quantification of somatic oncomutation.
Myers MB; McKinzie PB; Wang Y; Meng F; Parsons BL
Methods Mol Biol; 2014; 1105():345-63. PubMed ID: 24623241
[TBL] [Abstract][Full Text] [Related]
11. Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
Zheng L; Wang F; Qian C; Neumann RM; Cheville JC; Tindall DJ; Liu W
Hum Mutat; 2006 Oct; 27(10):1062-3. PubMed ID: 16941491
[TBL] [Abstract][Full Text] [Related]
12. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease.
Rapozo DC; Grinmann AB; Carvalho AT; de Souza HS; Soares-Lima SC; de Almeida Simão T; de Paiva D; Abby F; Albano RM; Pinto LF
Int J Colorectal Dis; 2009 Oct; 24(10):1141-8. PubMed ID: 19543899
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA, HRAS and KRAS gene mutations in human penile cancer.
Andersson P; Kolaric A; Windahl T; Kirrander P; Söderkvist P; Karlsson MG
J Urol; 2008 May; 179(5):2030-4. PubMed ID: 18355852
[TBL] [Abstract][Full Text] [Related]
15. RAS, BRAF, and TP53 gene mutations in Taiwanese colorectal cancer patients.
Chang YS; Chang SJ; Yeh KT; Lin TH; Chang JG
Onkologie; 2013; 36(12):719-24. PubMed ID: 24356563
[TBL] [Abstract][Full Text] [Related]
16. Sensitive quantification of somatic mutations using molecular inversion probes.
Hirani R; Connolly AR; Putral L; Dobrovic A; Trau M
Anal Chem; 2011 Nov; 83(21):8215-21. PubMed ID: 21942816
[TBL] [Abstract][Full Text] [Related]
17. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
18. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
[TBL] [Abstract][Full Text] [Related]
19. The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer.
Ouerhani S; Elgaaied AB
Cancer Biomark; 2011-2012; 10(6):259-66. PubMed ID: 22820081
[TBL] [Abstract][Full Text] [Related]
20. Mutation spectra of Kras and Tp53 in urethral and lung neoplasms in B6C3F1 mice treated with 3,3',4,4'-tetrachloroazobenzene.
Bhusari S; Malarkey DE; Hong HH; Wang Y; Masinde T; Nolan M; Hooth MJ; Lea IA; Vasconcelos D; Sills RC; Hoenerhoff MJ
Toxicol Pathol; 2014; 42(3):555-64. PubMed ID: 23703846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
